DoD Neurofibromatosis Postdoctoral Traineeship Award

Post Date

March 2nd 2010

Application Due Date

May 20th 2010

Funding Opportunity Number

W81XWH-10-NFRP-PTA

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

4

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $600000

• Award Range:

  $None - $None

Grant Description

The NFRP Postdoctoral Traineeship Award mechanism was first offered in FY09. Since then, 8 Postdoctoral Traineeship Award applications have been received, and 4 have been recommended for funding. The intent of the training award is to enable recent medical or other doctoral degree graduates to obtain the necessary experience to pursue an independent career in NF research. Candidates for this award should exhibit a strong desire to pursue a career in NF research. Under this award mechanism, the postdoctoral trainee is considered the Principal Investigator (PI) and, as such, should write the project narrative with appropriate direction from the mentor. The focus of these awards is on the PI, the mentor, and the training program and environment. These awards primarily provide salary support for the PI and require the active involvement of a designated mentor who is an established NF researcher, as evidenced by a demonstrated record of funding and publications. While the PI is not required to have previous experience in NF research, applications for this award must focus on NF research. DOD FY10 Neurofibromatosis Postdoctoral Traineeship Award 3 Areas of Encouragement: The FY10 NFRP encourages applications that specifically address the critical needs of the NF community in the following areas: • Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities; • Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain; • Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and • Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
  eReceipt HELP: 301-682-5507; help@cdmrp.org
  

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  cdmrp.pa@amedd.army.mil